Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
boston blog main
boston top stories
cholesterol
inclisiran
ldl
2
×
life sciences
mt sinai hospital
2
×
national blog main
national top stories
new york blog main
new york top stories
2
×
pcsk9
praluent
prashant vaishnava
2
×
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
2
×
alirocumab
biotech
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
circulation
clinical studies
clinical trials
data
david maron
detroit blog main
detroit top stories
esperion pharmaceuticals
evolocumab
fh foundation
heart attack
heart disease
What
cholesterol
drug
lowering
aces
announced
big
ceo
drugs
expensive
faces
financial
flexible
foe
healthcare
hint
inclisiran
inhibitors
key
known
meant
medco
medicine
medicines
nasdaq
new
open
passed
pcsk
pricing
remember
supposed
taken
test
tough
twice
wave
week
year
Language
unset
Current search:
ldl
×
sanofi
×
" mt sinai hospital "
×
amgen
×
" new york top stories "
×
" prashant vaishnava "
×
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)